Refine by
Lumen Bioscience Equipment & Supplies
6 equipment items found
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
Inflammatory bowel disease (IBD) is a systemic autoimmune disease, but it has an obvious nexus with the gastrointestinal tract. The two main sub-varieties—Crohn’s disease and ulcerative colitis—have many available treatments on the market today, but it remains a major unmet medical need: current treatments are costly, require inconvenient injection delivery, and come with severe ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
Supported in part by funding from the Bill & Melinda Gates Foundation, Lumen’s traveler’s diarrhea product is a cocktail of neutralizing monoclonal antibody-like protein biologics designed to bind and neutralize the primary causes of traveler’s diarrhea: the bacterial pathogens Campylobacter jejuni and enterotoxigenic E. coli. In addition to making life miserable for ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
We design and manufacture therapeutics against disease targets that have been inaccessible to the biopharmaceutical industry because of the astonishingly high cost of traditional methods. Now, for the first time, Lumen can make antibodies and other biologics at a cost that allows for daily, high-dose, oral and topical delivery. Our current programs target markets that are enormous, the treatment ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
Covid-19 is widely known as a respiratory disease, but its GI symptoms are well documented. The now-famous ACE2 receptor is abundantly expressed on the cells lining the GI tract, and over half of Covid-19 sufferers show symptoms of GI distress, and up to a quarter show only GI symptoms. GI infection by the virus can have serious long-term effects, and high enteric viral loads are thought to ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
Cardiometabolic disease (CMD)—a cluster of related conditions that includes obesity, diabetes, and cardiovascular disease—afflicts hundreds of millions of people worldwide, and the associated health and economic burdens continue to grow. An estimated 17.9 million people died from CMD in 2019, representing nearly a third of all global deaths. Of these deaths, 85% were due to heart ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
Traditionally considered a hospital-acquired infection, C. difficile is increasingly arising in the broader community. For this reason, the shelf-stable, orally delivered format of Lumen’s product is an important addition to the tool kit for treating and preventing this disease. Long-term consequences can include chronic diarrhea, severe intestinal inflammation, surgical resection, and ...